Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Takuya Kaminuma"'
Autor:
Yoshiyuki Miyazawa, Hiroshi Nakayama, Hidemasa Kawamura, Yuhei Miyasaka, Masahiro Onishi, Takuya Kaminuma, Yoshitaka Sekine, Hiroshi Matsui, Tatsuya Ohno, Kazuhiro Suzuki
Publikováno v:
Radiation Oncology, Vol 19, Iss 1, Pp 1-9 (2024)
Abstract Background The potential of carbon ion radiation therapy (CIRT) as a curative treatment for localized prostate cancer (PCa) has garnered attention due to its characteristic dose distribution. We prospectively collected and analyzed over five
Externí odkaz:
https://doaj.org/article/d1a693058ef14bb18df2186acb3b16cb
Autor:
Takeru Ohtaka, Ken Ando, Takahiro Oike, Shin-ei Noda, Takuya Kaminuma, Kazutoshi Murata, Tatsuya Ohno
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
ObjectiveTo evaluate the prognostic effect of tumor volume at diagnosis, tumor reduction ratio during external beam radiotherapy (EBRT) with central-shielding method, and cumulative minimal dose to 90% of the high-risk clinical target volume (CTVHR D
Externí odkaz:
https://doaj.org/article/7dda7236b1e5406eaa465108761a8832
Autor:
Nobuteru Kubo, Makoto Sakai, Hidemasa Kawamura, Takahiro Oike, Yoshiki Kubota, Mai Anakura, Akiko Adachi, Hiro Sato, Atsushi Musha, Naoko Okano, Takuya Kaminuma, Katsuyuki Shirai, Jun-ichi Saitoh, Satoshi Yokoo, Kazuaki Chikamatsu, Tatsuya Ohno
Publikováno v:
Radiation, Vol 1, Iss 3, Pp 183-193 (2021)
Background: Tooth loss reduces quality of life; however, little is known about tooth loss caused by carbon ion radiotherapy (CIRT). Here, we aimed to elucidate the incidence of tooth loss post-CIRT for head and neck tumors and to identify risk-predic
Externí odkaz:
https://doaj.org/article/8d80dbd610404d869aa78f295c02cd0e
Autor:
Kento Tomizawa, Ken Ando, Hirofumi Shimada, Takuya Kaminuma, Kazutoshi Murata, Takahiro Oike, Tatsuya Ohno
Publikováno v:
Clinical Case Reports, Vol 9, Iss 4, Pp 2099-2104 (2021)
Abstract Bevacizumab is a monoclonal antibody against vascular endothelial growth factor that exerts antitumor effect by preventing tumor angiogenesis. Gastrointestinal fistula is a common side effect of bevacizumab in combination with radiotherapy.
Externí odkaz:
https://doaj.org/article/bebb6a3457d24303bf366bf123c81a2c
Autor:
Shintaro Shiba, MD, PhD, Tetsuya Watanabe, MP, Takuya Kaminuma, MD, PhD, Etsuko Miyamoto, Motohiro Kawashima, MP, PhD, Daisuke Irie, MD, PhD, Ken Ando, MD, PhD, Tatsuya Ohno, MD, PhD,
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 3, Pp 100894- (2022)
Externí odkaz:
https://doaj.org/article/2cc56803d1474e16a718222ea6bdc9ee
Autor:
Shintaro Shiba, Kei Shibuya, Hiroyuki Katoh, Takuya Kaminuma, Masaya Miyazaki, Satoru Kakizaki, Ken Shirabe, Tatsuya Ohno, Takashi Nakano
Publikováno v:
Radiation Oncology, Vol 14, Iss 1, Pp 1-9 (2019)
Abstract Background We compared clinical outcomes of carbon ion radiotherapy and transarterial chemoembolization in the treatment of hepatocellular carcinoma. Methods Data of 477 patients with hepatocellular carcinoma who had undergone carbon ion rad
Externí odkaz:
https://doaj.org/article/ba4e84811fbf473cb406bc8783d7c971
Autor:
Shintaro Shiba, Masahiko Okamoto, Hiroki Kiyohara, Tatsuya Ohno, Takuya Kaminuma, Takayuki Asao, Hitoshi Ojima, Ken Shirabe, Hiroyuki Kuwano, Takashi Nakano
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Background and purpose: Favorable clinical outcomes of carbon-ion radiotherapy for pelvic recurrence of rectal cancer have been described by previous prospective phase I/II and II studies; however, these studies were performed at a single institution
Externí odkaz:
https://doaj.org/article/3fc17de5f367484ba3f4a13731e8fd1d
Autor:
Yosuke Takakusagi, Hidemasa Kawamura, Masahiko Okamoto, Takuya Kaminuma, Nobuteru Kubo, Tatsuji Mizukami, Hiro Sato, Masahiro Onishi, Nobuaki Ohtake, Tetsuo Sekihara, Takashi Nakano
Publikováno v:
PLoS ONE, Vol 14, Iss 2, p e0211370 (2019)
BackgroundRecently, the clinical outcome of prostate cancer treated by hypofractionated radiation therapy has been reported. However, there are few reports from Japan. In Hidaka Hospital, hypofractionated intensity-modulated radiotherapy (HIMRT) for
Externí odkaz:
https://doaj.org/article/a52e9cc7651d49be950d7ad1a1de2bbd
Autor:
Osamu Nikkuni, Nobuteru Kubo, Satoshi Yokoo, Masato Shino, Shota Ida, Katsuyuki Shirai, Neck Tumors, Tatsuya Ohno, Takuya Kaminuma, Hiro Sato, Naoko Okano, Masaru Ogawa, Jun-ichi Saitoh, Hidemasa Kawamura, Yukihiro Takayasu, Kazuaki Chikamatsu, Atsushi Musha
Publikováno v:
Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 34:280-286
Objective Data on the long-term outcomes of carbon-ion radiotherapy for non-squamous cell carcinomas are rare. Gunma University has been utilizing carbon-ion radiotherapy as a treatment for head and neck cancer since 2010. This study aimed to evaluat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba3efa9fcb3dc8b3ac303eee83551f6e
https://doi.org/10.1016/j.ajoms.2021.10.012
https://doi.org/10.1016/j.ajoms.2021.10.012
Autor:
Hirofumi Shimada, Kazutoshi Murata, Ken Ando, Takuya Kaminuma, Kento Tomizawa, Takahiro Oike, Tatsuya Ohno
Publikováno v:
Clinical Case Reports
Clinical Case Reports, Vol 9, Iss 4, Pp 2099-2104 (2021)
Clinical Case Reports, Vol 9, Iss 4, Pp 2099-2104 (2021)
Bevacizumab is a monoclonal antibody against vascular endothelial growth factor that exerts antitumor effect by preventing tumor angiogenesis. Gastrointestinal fistula is a common side effect of bevacizumab in combination with radiotherapy. This case
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::956b5c9267f22bcd6a1adb5b9d23d329
http://europepmc.org/articles/PMC8077241
http://europepmc.org/articles/PMC8077241